Prevalence of 21-hydroxylase-deficient nonclassic adrenal hyperplasia and insulin resistance among hirsute women from Puerto Rico. (Q51554990)

7 April 2018

title

Prevalence of 21-hydroxylase-deficient nonclassic adrenal hyperplasia and insulin resistance among hirsute women from Puerto Rico. (English)

1 reference

7 April 2018

1 reference

1 reference

Romaguera J

1

1 reference

7 April 2018

Moran C

2

1 reference

7 April 2018

Diaz-Montes TP

3

1 reference

7 April 2018

Hines GA

4

1 reference

7 April 2018

Cruz RI

5

1 reference

7 April 2018

Azziz R

6

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 July 2000

1 reference

7 April 2018

published in

Fertility and Sterility

1 reference

7 April 2018

volume

74

1 reference

7 April 2018

issue

1

1 reference

7 April 2018

page(s)

59-62

1 reference

7 April 2018

The Incidence of Late-Onset Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency among Hirsute Women*

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

21-Hydroxylase deficiency in female hyperandrogenism: screening and diagnosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

Late-onset adrenal hyperplasia in hirsutism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

Prevalence of late-onset adrenal hyperplasia in postmenarchal hirsutism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

Assessment of the one hour adrenocorticotrophic hormone test in the diagnosis of attenuated 21-hydroxylase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

Late-onset adrenal hyperplasia in north Indian hirsute women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

Secondary biosynthetic defects in women with late-onset congenital adrenal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

Late-onset congenital adrenal hyperplasia in women with hirsutism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

Prevalence rates for diabetes mellitus in Puerto Rico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

Prevalence of diabetes in Mexican Americans, Cubans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey, 1982-1984

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

Assessing obesity: classification and epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

Upper body obesity and hyperinsulinemia are associated with anovulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

Acute adrenocorticotropin-(1-24) (ACTH) adrenal stimulation in eumenorrheic women: reproducibility and effect of ACTH dose, subject weight, and sampling time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

Clinical review 26: Insulin resistance in obese and nonobese man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

3 beta-hydroxysteroid dehydrogenase deficiency in hyperandrogenism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

Measurement of total serum testosterone levels using commercially available kits: high degree of between-kit variability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. The DECODE-study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

Potential impact of a change in the diagnostic criteria for diabetes mellitus on the prevalence of abnormal glucose tolerance in a local community at risk of diabetes: impact of new diagnostic criteria for diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900566-5

10.1016/S0015-0282(00)00566-5

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

10899497

1 reference

7 April 2018